Read more about From disease detection to biomass forecasting: AI improves aquaculture risk strategy on Devdiscourse ...

In its earnings report, Nvidia gave guidance for the first quarter that sailed past estimates, with growth projected to reach ...

Neurogene received FDA Breakthrough Therapy Designation for NGN-401 in Rett Syndrome, driving a >25% share price surge. Click ...

Nvidia Corporation’s pricing power amid AI capex constraints and the failed $100B OpenAI deal may signal upside. Click for ...

Looking beyond the chipmakers may reveal some great growth opportunities at fair prices.

CoreWeave shares tumbled after the Nvidia-backed AI infrastructure firm issued a softer-than-expected revenue outlook.

Enterprise use cases driving demand for AI Agent Development Services in 2026. Explore automation, autonomous AI agents, ...

This upward trajectory toward the $330 mark is primarily fueled by Adobe's aggressive integration of generative AI across its Creative Cloud and Experience Cloud suites.

OXB, an Oxford-based cell and gene therapy CDMO, is anticipating significant growth in its latest year-end trading update.

March 2026 opens the spring cycle of change — and it does so unexpectedly decisively. The energies of Pisces and Aries are ...

Kalshi's prediction markets could be better than CPI surveys or tate decision forecasts, while Polymarket beats analysts on earnings, according to two new studies.

Goliath Resources Limited (the "Company" or "Goliath") is pleased to report the completed gold-equivalent assay results for the remaining 56 holes drilled in 2025 at the Surebet Discovery on its 100% ...